The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lebel Francois since year 2005.
The trader's CIK number is 1038704.
At the time of this reporting, Lebel Francois is the Executive Vice President R&D of Ziopharm Oncology Inc .
(stock ticker symbol ZIOP).
See this page for all insider trading activities at Ziopharm Oncology Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-06-09||ZIOP||Ziopharm Oncology Inc||Sale||50,000||10.12||505,999|
|2015-06-09||ZIOP||Ziopharm Oncology Inc||Option Ex||50,000||4.34||217,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lebel Francois (Executive Vice President R&D of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.